Format

Send to

Choose Destination
Seizure. 2019 Dec;73:43-45. doi: 10.1016/j.seizure.2019.10.007. Epub 2019 Oct 31.

Clinical Letter: A case report of targeted therapy with sirolimus for NPRL3 epilepsy.

Author information

1
Division of Child Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States. Electronic address: Marissa.Vawter@cchmc.org.
2
Division of Child Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States. Electronic address: David.Franz@cchmc.org.
3
Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States; Department of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States. Electronic address: Christine.Fuller@cchmc.org.
4
Division of Child Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States. Electronic address: Hansel.Greiner@cchmc.org.

KEYWORDS:

Cortical malformation; GATOR; NPRL3; Refractory epilepsy; Sirolimus

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center